Avricore Health (AVCRF) Change in Accured Expenses (2009 - 2026)
Avricore Health (AVCRF) posted quarterly Change in Accured Expenses of $157226.2 for Q1 2026, up 256.93% year-over-year from $44049.6 in Q1 2025, and up 59.16% quarter-over-quarter from $98786.5 in Q4 2025.
Avricore Health (AVCRF) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Change in Accured Expenses for 18 consecutive years, with $157226.2 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 256.93% year-over-year to $157226.2; the TTM figure through Mar 2026 stood at $146857.5 (up 233.74% YoY), while the FY2025 annual figure was -$112490.7, up 2.77% from the prior year.
- Change in Accured Expenses climbed to $157226.2 in Q1 2026 per AVCRF's latest filing, from $98786.5 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $216364.6 in Q3 2023 and bottomed at -$109051.7 in Q2 2024.
- Historically, Change in Accured Expenses has averaged $23552.1 across 5 years, with a median of $13097.7 in 2024.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 1619.19% — and 2023, when it slumped 384.7%.
- Avricore Health's Change in Accured Expenses stood at -$17773.0 in 2022, then plunged by 384.7% to -$86146.3 in 2023, then jumped by 139.4% to $33942.0 in 2024, then surged by 191.05% to $98786.5 in 2025, then surged by 59.16% to $157226.2 in 2026.
- Business Quant data shows AVCRF's Change in Accured Expenses at $157226.2 in Q1 2026, $98786.5 in Q4 2025, and -$7746.7 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -39.33 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 92.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -24.00 Mn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.23 Bn |
| Mar 31, 2026 | 157.23 Bn |
| Dec 31, 2025 | 98.79 Bn |
| Dec 31, 2025 | 98.79 Bn |
| Sep 30, 2025 | -7.75 Bn |
| Sep 30, 2025 | -7.75 Bn |
| Jun 30, 2025 | -101.41 Bn |
| Jun 30, 2025 | -101.41 Bn |
| Mar 31, 2025 | -100.19 Bn |
| Mar 31, 2025 | -100.19 Bn |
| Sep 30, 2024 | 33.83 Bn |
| Sep 30, 2024 | 33.83 Bn |
| Jun 30, 2024 | -108.24 Bn |
| Jun 30, 2024 | -108.24 Bn |
| Mar 31, 2024 | 65.49 Bn |
| Mar 31, 2024 | 65.49 Bn |
| Dec 31, 2023 | -86.15 Bn |
| Dec 31, 2023 | -86.15 Bn |
| Sep 30, 2023 | 216.36 Bn |
| Sep 30, 2023 | 216.36 Bn |